Business C-RAD AB is a company with three subsidiaries; C-RAD Positioning AB, C-RAD Imaging AB and C-RAD Innovation AB. The parent company is responsible for economy, accounting and marketing and sales of the company’s products and solutions. All product development is done in the different subsidiaries.
Business concept Through detailed knowledge about the radiotherapy business and its customer requirements we shall offer products for positioning, monitoring, tumor localization and radiation therapy. Our customers are radiation treatment clinics and diagnostics departments in hospitals worldwide. The aim is to contribute to higher level of quality and efficiency at the customer. The products from the C-RAD group are distinguished by a high level of innovation which is achieved by close collaboration by prominent research institutes and by developing a high level of competence within key areas such as software development and detector technology in radiation physics.
Background Cancer is a disease that affects about one third of the population in the Western World, which means about 10 millions new cancer patients per year and that there is an increase of about 3% per year. Despite this is it an increasing number of patient cured which is mainly due to improvements in diagnostic and treatment methods. The main treatment methods are surgery, radiotherapy and chemotherapy. A typical cancer treatment is often a combination of these methods. The number of patients cured is on average about 50%. With the development of better diagnostic and therapeutic methods and products has the number of patients cured increased more within radiotherapy compared to the other methods and this trend is expected to increase within the next years. Learn more about C-Rad »
NASDAQ OMX First North is an alternative market, operated by the different exchanges within NASDAQ OMX. It does not have the legal status as an EU-regulated market.
Companies at First North are subject to the rules of First North and not the legal requirements for admission to trading on a regulated market. The risk in such an investment may be higher than on the main market.
